These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 37837493)
21. The experience of itch in children with psoriasis: A qualitative exploration of the Itch Numeric Rating Scale. Mannix S; Edson-Heredia E; Paller AS; Yosipovitch G; Burge R; Kleinman L Pediatr Dermatol; 2021 Mar; 38(2):405-412. PubMed ID: 33336430 [TBL] [Abstract][Full Text] [Related]
22. Itching is a significant problem and a mediator between disease severity and quality of life for patients with psoriasis: results from a randomized controlled trial. Zhu B; Edson-Heredia E; Guo J; Maeda-Chubachi T; Shen W; Kimball AB Br J Dermatol; 2014 Nov; 171(5):1215-9. PubMed ID: 24749812 [TBL] [Abstract][Full Text] [Related]
23. Serlopitant for psoriatic pruritus: A phase 2 randomized, double-blind, placebo-controlled clinical trial. Pariser DM; Bagel J; Lebwohl M; Yosipovitch G; Chien E; Spellman MC J Am Acad Dermatol; 2020 Jun; 82(6):1314-1320. PubMed ID: 32007513 [TBL] [Abstract][Full Text] [Related]
24. Tildrakizumab improves high burden skin symptoms, impaired sleep and quality of life of moderate-to-severe plaque psoriasis patients in conditions close to clinical practice. Costanzo A; Llamas-Velasco M; Fabbrocini G; Cuccia A; Rivera-Diaz R; Gaarn Du Jardin K; Kasujee I; Puig L; Carrascosa JM J Eur Acad Dermatol Venereol; 2023 Oct; 37(10):2004-2015. PubMed ID: 37246505 [TBL] [Abstract][Full Text] [Related]
25. Phase 3 Trials of Tapinarof Cream for Plaque Psoriasis. Lebwohl MG; Stein Gold L; Strober B; Papp KA; Armstrong AW; Bagel J; Kircik L; Ehst B; Hong HC; Soung J; Fromowitz J; Guenthner S; Piscitelli SC; Rubenstein DS; Brown PM; Tallman AM; Bissonnette R N Engl J Med; 2021 Dec; 385(24):2219-2229. PubMed ID: 34879448 [TBL] [Abstract][Full Text] [Related]
26. Predicting Factors and Clinical Characteristics of Pruritus in Psoriasis: A Cross-Sectional Survey. Morariu SH; Cotoi OS; Tiucă OM; Ambros M; Ilcuș RI; Garaga L; Raluca A; Horea D; Bălan AB; Husariu M; Gînj A; Țiplic A; Hidi A; Szabo B; Stan RA; Nicolescu AC Life (Basel); 2024 Jun; 14(7):. PubMed ID: 39063581 [TBL] [Abstract][Full Text] [Related]
27. Pruritus and quality of life in moderate-to-severe plaque psoriasis: post hoc explorative analysis from the PRISTINE study. Mrowietz U; Chouela EN; Mallbris L; Stefanidis D; Marino V; Pedersen R; Boggs RL J Eur Acad Dermatol Venereol; 2015 Jun; 29(6):1114-20. PubMed ID: 25376448 [TBL] [Abstract][Full Text] [Related]
28. Evaluation of the benefit of thermal spa therapy in plaque psoriasis: the PSOTHERMES randomized clinical trial. Beylot-Barry M; Mahé E; Rolland C; de la Bretèque MA; Eychenne C; Charles J; Payen C; Machet L; Vermorel C; Foote A; Roques C; Bosson JL Int J Biometeorol; 2022 Jun; 66(6):1247-1256. PubMed ID: 35347400 [TBL] [Abstract][Full Text] [Related]
29. Interplay of Itch and Psyche in Psoriasis: An Update. Reich A; Mędrek K; Szepietowski JC Acta Derm Venereol; 2016 Aug; 96(217):55-7. PubMed ID: 27282194 [TBL] [Abstract][Full Text] [Related]
34. The Genetics of Chronic Itch: Gene Expression in the Skin of Patients with Atopic Dermatitis and Psoriasis with Severe Itch. Nattkemper LA; Tey HL; Valdes-Rodriguez R; Lee H; Mollanazar NK; Albornoz C; Sanders KM; Yosipovitch G J Invest Dermatol; 2018 Jun; 138(6):1311-1317. PubMed ID: 29317264 [TBL] [Abstract][Full Text] [Related]
35. The Worst Itch Numeric Rating Scale for patients with moderate to severe plaque psoriasis or psoriatic arthritis. Naegeli AN; Flood E; Tucker J; Devlen J; Edson-Heredia E Int J Dermatol; 2015 Jun; 54(6):715-22. PubMed ID: 25515935 [TBL] [Abstract][Full Text] [Related]
36. Impact of Avène hydrotherapy on the quality of life of atopic and psoriatic patients. Taieb C; Sibaud V; Merial-Kieny C J Eur Acad Dermatol Venereol; 2011 Feb; 25 Suppl 1():24-9. PubMed ID: 21175871 [TBL] [Abstract][Full Text] [Related]